arginyl-glycyl-aspartic acid has been researched along with Diabetic Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gondaliya, P; Jogi, H; Kalia, K; Raval, N; Tekade, RK | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Cyclo-RGD Truncated Polymeric Nanoconstruct with Dendrimeric Templates for Targeted HDAC4 Gene Silencing in a Diabetic Nephropathy Mouse Model.
Topics: Animals; Dendrimers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Carriers; Drug Stability; Gene Silencing; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Kidney; Male; Mice; Nanoparticles; Oligopeptides; Peptides, Cyclic; Podocytes; Primary Cell Culture; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Streptozocin | 2021 |